News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 29, 2016

What To Know About The Optune Device

Episodes in this series

EP. 1 What is Glioblastoma?

EP. 1 What is Glioblastoma?

EP. 2 Treating Glioblastoma

EP. 2 Treating Glioblastoma

EP. 3 What To Know About The Optune Device

EP. 3 What To Know About The Optune Device

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Registration is now open for the National Caregivers Self-Care and Tools online educational event.

Registration Open for the National Caregivers Self-Care and Tools Webinar Hosted by the End Brain Cancer Initiative

ByThe End Brain Cancer Initiative

October 16th 2025

For nearly 30 years, Nora Ambros lived with a constant, painful reminder of her first battle with breast cancer.

A Survivor's 30-Year Wait for Lymphedema Relief Ends with Hackensack's New Supermicrosurgery Robotic Procedure

ByHackensack Meridian Health

October 16th 2025

The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma: © stock.adobe.com.

FDA Grants Orphan Drug Status to Cintredekin Besudotox for Glioblastoma

BySpencer Feldman

October 7th 2025

Dr. Tanja Gruber

What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?

ByDr. Tanja A. Gruber

October 6th 2025

Image of woman.

Safe Food Practices at Home for Immunocompromised Patients With Cancer

ByHeather Ann Yonker

September 30th 2025

Trending on CURE

Tecentriq Plus BCG Does Not Improve Outcomes in Some With Bladder Cancer

Areola Tattooing Helped Stephanie Wachtel Reclaim Confidence After Cancer

Supervised Physical Activity Does Not Improve Quality of Life in Metastatic Cancer

Lenvima Combo Fails to Extend Survival in Esophageal Cancer

Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.